Entropic Biosciences is aprivately held biotechnology company founded in 2023 that develops proprietary3D NAM tissue models to accelerate drug discovery, precision medicine, andregenerative medicine research. The NAM models aim to recreate physiologicallyrelevant human models that will reduce the cost and time required fortherapeutic development while advancing applications in cancer research,toxicology, and tissue engineering.

